| ASSET | MONTH | % RETURN |
|---|---|---|
GDS (GDS) | February 2025 | 73.21% |
VNET Group Inc DRC (VNET) | February 2025 | 69.18% |
Tuya Inc ADR (TUYA) | February 2025 | 52.7% |
SpringWorks Therapeutics (SWTX) | February 2025 | 44.62% |
Liberty Global PLC Class B (LBTYB) | February 2025 | 44.25% |
GeneDx (WGS) | February 2025 | 43.53% |
WeRide Inc American Depositary Shares (WRD) | February 2025 | 39.16% |
Ast Spacemobile (ASTS) | February 2025 | 38.06% |
Lufax (LU) | February 2025 | 36.52% |
Zai Lab (ZLAB) | February 2025 | 28.91% |
Compass (COMP) | February 2025 | 28.9% |
Light & Wonder (LNW) | February 2025 | 28.81% |
Bilibili (BILI) | February 2025 | 28.13% |
SSR Mining (SSRM) | February 2025 | 26.88% |
Lions Gate Entertainment (LGF.A) | February 2025 | 26.63% |
Pony AI Inc American Depositary Shares (PONY) | February 2025 | 25.77% |
Vicor (VICR) | February 2025 | 25.7% |
SolarWinds (SWI) | February 2025 | 25.38% |
HUTCHMED DRC (HCM) | February 2025 | 24.94% |
Lions Gate Entertainment (LGF.B) | February 2025 | 24.2% |
Grifols SA ADR (GRFS) | February 2025 | 23.95% |
Advantage Solutions (ADVWW) | February 2025 | 23.91% |
ESCO Technologies (ESE) | February 2025 | 22.88% |
Verona Pharma PLC ADR (VRNA) | February 2025 | 20.59% |
Ascendis Pharma A-S (ASND) | February 2025 | 20.57% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
